悦康药业
(688658)
| 流通市值：113.40亿 | | | 总市值：113.40亿 |
| 流通股本：4.50亿 | | | 总股本：4.50亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,011,739,524.68 | 1,454,983,942.63 | 1,331,795,660.8 | 1,550,906,157.27 |
| 交易性金融资产 | 230,116,247.37 | 100,032,500 | 160,255,000 | 50,000,000 |
| 应收票据及应收账款 | 516,528,868.11 | 638,565,460.04 | 716,133,503.13 | 924,959,251.42 |
| 其中：应收票据 | 49,642,636.02 | 63,281,191.38 | 104,434,969.17 | 114,651,932.78 |
| 应收账款 | 466,886,232.09 | 575,284,268.66 | 611,698,533.96 | 810,307,318.64 |
| 应收款项融资 | 69,227,361.67 | 66,446,318.33 | 89,297,315.12 | 51,879,965.87 |
| 预付款项 | 36,550,245.07 | 57,543,794.13 | 52,666,132.56 | 52,313,091.37 |
| 其他应收款合计 | 154,444,300.57 | 27,802,937.61 | 18,781,063.11 | 9,840,372.44 |
| 存货 | 578,866,617.62 | 645,468,495.43 | 757,335,702.72 | 749,353,079.29 |
| 合同资产 | - | - | - | 395,977.59 |
| 其他流动资产 | 43,280,220.1 | 46,964,273.57 | 31,667,598.69 | 36,568,063.19 |
| 流动资产合计 | 2,640,753,385.19 | 3,037,807,721.74 | 3,157,931,976.13 | 3,426,215,958.44 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 其他非流动金融资产 | 132,637,106.37 | 32,599,108.86 | 32,599,108.86 | 25,254,214.78 |
| 固定资产 | 1,378,178,556.34 | 1,416,437,299.87 | 1,437,936,396.92 | 1,440,574,782.58 |
| 在建工程 | 610,666,353.68 | 596,180,843.14 | 539,860,332.13 | 525,967,119.77 |
| 使用权资产 | 17,234,207.62 | 19,363,338.49 | 21,492,469.36 | 29,482,737.5 |
| 无形资产 | 166,367,783.26 | 168,872,558.06 | 175,006,747.38 | 170,019,944.71 |
| 开发支出 | 287,298,012.84 | 287,800,976.2 | 285,702,750.87 | 302,956,603.16 |
| 长期待摊费用 | 6,464,402.09 | 7,715,932.93 | 8,184,508.89 | 8,738,102.84 |
| 递延所得税资产 | 32,179,169.52 | 28,081,564.97 | 30,323,871.6 | 19,225,227.64 |
| 其他非流动资产 | 17,051,859.46 | 15,972,897.88 | 48,574,262.58 | 54,775,511.27 |
| 非流动资产合计 | 2,648,577,451.18 | 2,573,524,520.4 | 2,580,180,448.59 | 2,577,494,244.25 |
| 资产总计 | 5,289,330,836.37 | 5,611,332,242.14 | 5,738,112,424.72 | 6,003,710,202.69 |
| 流动负债: | | | | |
| 短期借款 | 88,292,002.39 | 103,133,365.43 | 112,965,265.65 | 202,715,515.62 |
| 应付票据及应付账款 | 461,778,334.19 | 550,531,579.56 | 641,995,693.19 | 607,972,299.99 |
| 其中：应付票据 | 94,577,528 | 176,945,535.95 | 210,653,128.29 | 164,390,533.56 |
| 应付账款 | 367,200,806.19 | 373,586,043.61 | 431,342,564.9 | 443,581,766.43 |
| 合同负债 | 31,157,672.61 | 56,503,828.64 | 44,543,636.74 | 23,926,168.4 |
| 应付职工薪酬 | 50,551,707.69 | 50,495,945.69 | 55,079,110.75 | 47,657,524.52 |
| 应交税费 | 33,108,935.59 | 29,314,380.52 | 24,966,716.57 | 83,487,431.81 |
| 其他应付款合计 | 405,218,680.77 | 504,387,500.99 | 559,327,114.43 | 744,555,564.24 |
| 一年内到期的非流动负债 | 257,142,704.61 | 100,092,905.85 | 60,904,399.1 | 49,322,183.74 |
| 其他流动负债 | 3,938,166.48 | 7,292,600.72 | 5,729,645.69 | 3,056,334.89 |
| 流动负债合计 | 1,331,188,204.33 | 1,401,752,107.4 | 1,505,511,582.12 | 1,762,693,023.21 |
| 非流动负债: | | | | |
| 长期借款 | 343,051,798.21 | 538,089,976.54 | 516,974,334.54 | 445,674,633.6 |
| 租赁负债 | 9,605,272.93 | 12,048,253.91 | 14,461,905.67 | 21,191,429.14 |
| 递延收益 | 122,709,036.41 | 123,983,472.8 | 116,207,926.76 | 102,240,785.31 |
| 非流动负债合计 | 475,366,107.55 | 674,121,703.25 | 647,644,166.97 | 569,106,848.05 |
| 负债合计 | 1,806,554,311.88 | 2,075,873,810.65 | 2,153,155,749.09 | 2,331,799,871.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 450,000,000 | 450,000,000 | 450,000,000 | 450,000,000 |
| 资本公积 | 2,645,177,299.84 | 2,645,177,299.84 | 2,645,177,299.84 | 2,645,177,299.84 |
| 减:库存股 | 100,021,280.95 | 100,021,280.95 | 100,021,280.95 | 100,021,280.95 |
| 盈余公积 | 192,921,037.29 | 192,921,037.29 | 192,921,037.29 | 162,204,334.22 |
| 未分配利润 | 290,723,765.38 | 340,281,775.76 | 389,552,910.59 | 506,277,648.08 |
| 归属于母公司股东权益合计 | 3,478,800,821.56 | 3,528,358,831.94 | 3,577,629,966.77 | 3,663,638,001.19 |
| 少数股东权益 | 3,975,702.93 | 7,099,599.55 | 7,326,708.86 | 8,272,330.24 |
| 股东权益合计 | 3,482,776,524.49 | 3,535,458,431.49 | 3,584,956,675.63 | 3,671,910,331.43 |
| 负债和股东权益合计 | 5,289,330,836.37 | 5,611,332,242.14 | 5,738,112,424.72 | 6,003,710,202.69 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-03-15 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |